Clinicopathological features | Univariate analysis | Multivariate analysis | ||
---|---|---|---|---|
Hazard ratio (HR) (95% CI) | P | HR (95% CI) | P | |
Differentiation | 2.056 (1.318–3.209) | 0.002 | 1.516 (0.963–2.387) | 0.073 |
UICC stage | 16.236 (9.592–27.281) | < 0.001 | 7.416 (4.218–13.038) | < 0.001 |
Metastasis | 12.001 (6.689–21.532) | < 0.001 | 8.819 (4.540–17.134) | < 0.001 |
Agg (CT) | 0.272 (0.161–0.460) | < 0.001 | 0.401 (0.217–0.739) | 0.003 |
FOL-I (CT) | 0.212 (0.093–0.485) | < 0.001 | 0.267 (0.095–0.749) | 0.012 |
FOL-II (CT) | 0.226 (0.056–0.917) | 0.007 | 0.267 (0.063–1.125) | 0.072 |
Total (CT)* | 0.319 (0.209–0.487) | < 0.001 | 0.560 (0.335–0.936) | 0.027 |
Agg (IM) | 0.335 (0.226–0.497) | < 0.001 | 0.762 (0.469–1.236) | 0.271 |
FOL-I (IM) | 0.624 (0.419–0.931) | 0.021 | 0.774 (0.494–1.214) | 0.265 |
FOL-II (IM) | 0.432 (0.201–0.932) | 0.032 | 0.699 (0.314–1.553) | 0.379 |
Total (IM)* | 0.356 (0.226–0.561) | < 0.001 | 0.640 (0.383–1.068) | 0.088 |
Overall (CT + IM)* | 0.273 (0.165–0.451) | < 0.001 | 0.435 (0.246–0.769) | 0.004 |